CA2919195C - Assembly for an autoinjector device - Google Patents
Assembly for an autoinjector device Download PDFInfo
- Publication number
- CA2919195C CA2919195C CA2919195A CA2919195A CA2919195C CA 2919195 C CA2919195 C CA 2919195C CA 2919195 A CA2919195 A CA 2919195A CA 2919195 A CA2919195 A CA 2919195A CA 2919195 C CA2919195 C CA 2919195C
- Authority
- CA
- Canada
- Prior art keywords
- syringe
- axially
- guard element
- syringe support
- assembly according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940090047 auto-injector Drugs 0.000 title claims description 27
- 239000003814 drug Substances 0.000 claims description 20
- 239000013583 drug formulation Substances 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 17
- 230000000295 complement effect Effects 0.000 claims description 16
- 239000013011 aqueous formulation Substances 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- -1 NaCI Substances 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 102000015636 Oligopeptides Human genes 0.000 description 4
- 108010038807 Oligopeptides Proteins 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
- 102000015696 Interleukins Human genes 0.000 description 3
- 108010063738 Interleukins Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 229920001427 mPEG Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229940071643 prefilled syringe Drugs 0.000 description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 208000027205 Congenital disease Diseases 0.000 description 1
- 208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010014824 Endotoxic shock Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000009329 Graft vs Host Disease Diseases 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003816 Interleukin-13 Human genes 0.000 description 1
- 108090000176 Interleukin-13 Proteins 0.000 description 1
- 102100033461 Interleukin-17A Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 102000000646 Interleukin-3 Human genes 0.000 description 1
- 102000004388 Interleukin-4 Human genes 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 102000000743 Interleukin-5 Human genes 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 206010049088 Osteopenia Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 206010054094 Tumour necrosis Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- MSYKRHVOOPPJKU-BDAKNGLRSA-N brivaracetam Chemical compound CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1 MSYKRHVOOPPJKU-BDAKNGLRSA-N 0.000 description 1
- 229960002161 brivaracetam Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006359 hepatoblastoma Diseases 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 208000036260 idiopathic disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 102000014909 interleukin-1 receptor activity proteins Human genes 0.000 description 1
- 108040006732 interleukin-1 receptor activity proteins Proteins 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- ANWPENAPCIFDSZ-BQBZGAKWSA-N seletracetam Chemical compound CC[C@@H](C(N)=O)N1C[C@@H](C=C(F)F)CC1=O ANWPENAPCIFDSZ-BQBZGAKWSA-N 0.000 description 1
- 229950000852 seletracetam Drugs 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 125000006850 spacer group Chemical class 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Chemical group 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 206010044412 transitional cell carcinoma Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3135—Syringe barrels characterised by constructional features of the proximal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2033—Spring-loaded one-shot injectors with or without automatic needle insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M2005/2418—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic comprising means for damping shocks on ampoule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3142—Modular constructions, e.g. supplied in separate pieces to be assembled by end-user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/19—Constructional features of carpules, syringes or blisters
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1313888.8 | 2013-08-02 | ||
| GBGB1313888.8A GB201313888D0 (en) | 2013-08-02 | 2013-08-02 | Assembly for an autoinjector device |
| PCT/GB2014/052387 WO2015015230A2 (en) | 2013-08-02 | 2014-08-04 | Assembly for an autoinjector device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2919195A1 CA2919195A1 (en) | 2015-02-05 |
| CA2919195C true CA2919195C (en) | 2022-04-12 |
Family
ID=49224085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2919195A Active CA2919195C (en) | 2013-08-02 | 2014-08-04 | Assembly for an autoinjector device |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10500341B2 (enExample) |
| EP (1) | EP3027248B1 (enExample) |
| JP (1) | JP6667165B2 (enExample) |
| CN (1) | CN105555337B (enExample) |
| AU (1) | AU2014298151B2 (enExample) |
| BR (1) | BR112016002188B1 (enExample) |
| CA (1) | CA2919195C (enExample) |
| ES (1) | ES2861348T3 (enExample) |
| GB (2) | GB201313888D0 (enExample) |
| WO (1) | WO2015015230A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201707738A (zh) * | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 注射器支架及自動注射器（二） |
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| CA3099359A1 (en) | 2018-05-24 | 2019-11-28 | Novartis Ag | Automatic drug delivery device |
| EP3626291A1 (en) | 2018-09-21 | 2020-03-25 | Regeneron Pharmaceuticals, Inc. | Needle shield grip device |
| USD1029238S1 (en) * | 2022-04-27 | 2024-05-28 | Bespak Europe Limited | Inhaler |
| USD1028220S1 (en) * | 2022-11-30 | 2024-05-21 | SYNERGY LIFE SCIENCE, Inc. | Portable nebulizer |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4333456A (en) * | 1981-02-09 | 1982-06-08 | Sterling Drug Inc. | Self-aspirating hypodermic syringe and self-aspirating assembly therefor |
| US4985000A (en) | 1986-09-30 | 1991-01-15 | Minnesota Mining And Manufacturing Co. | Shielded cable termination assembly |
| US6506195B2 (en) | 1992-09-30 | 2003-01-14 | Staar Surgical Company, Inc. | Deformable intraocular lens insertion system |
| US6454746B1 (en) | 1997-06-04 | 2002-09-24 | Eli Lilly And Company | Medication delivery apparatus |
| US6223733B1 (en) | 1997-07-08 | 2001-05-01 | Siemens Canada Limited | Exhaust gas recirculation valve |
| JP3052991U (ja) | 1998-04-02 | 1998-10-13 | オージーケー技研株式会社 | ハンドルグリップ構造 |
| US7455661B2 (en) * | 1998-04-17 | 2008-11-25 | Becton, Dickinson And Company | Safety shield system for prefilled syringe |
| US6305908B1 (en) | 1998-06-19 | 2001-10-23 | Abbott Laboratories | Infusion pump extruded metal housing with elastomeric end caps |
| US6884493B2 (en) | 2000-06-13 | 2005-04-26 | Milliken & Company | Patterned carpet and method |
| US7195623B2 (en) * | 2001-03-27 | 2007-03-27 | Eli Lilly And Company | Kit including side firing syringe needle for preparing a drug in an injection pen cartridge |
| US6669664B2 (en) | 2001-09-07 | 2003-12-30 | Avant Drug Delivery Systems, Inc. | Vacuum control cycle for jet injector |
| US20050131355A1 (en) | 2002-06-12 | 2005-06-16 | Fritz Kirchhofer | Injection or infusion device with refined surface |
| CA2495238A1 (en) | 2002-08-26 | 2004-03-04 | Penjet Corporation | Apparatus for needle-less injection with a degassed fluid |
| DE10351598A1 (de) * | 2003-11-05 | 2005-06-16 | Tecpharma Licensing Ag | Autoinjektionsvorrichtung |
| WO2005070481A1 (en) | 2004-01-23 | 2005-08-04 | The Medical House Plc | Injection device |
| IL162854A (en) * | 2004-07-04 | 2011-08-31 | Igal Sharon | Syringe assembly |
| WO2006077466A2 (en) | 2005-01-18 | 2006-07-27 | Wockhardt Americas Inc | Pen shaped medication injection devices |
| JP2008543500A (ja) | 2005-06-21 | 2008-12-04 | イーライ リリー アンド カンパニー | 医薬品注射用の器具及び方法 |
| US7647929B2 (en) * | 2005-09-28 | 2010-01-19 | Nellcor Puritan Bennett Llc | Medical device tube having a flange with opposing support ears for improved alignment and retention of an inner cannula in an outer cannula |
| EA013338B1 (ru) * | 2005-12-05 | 2010-04-30 | Чжуншань Ботай Фармасьютик Инструментс Ко., Лтд. | Автоматический шприц |
| GB0601309D0 (en) * | 2006-01-23 | 2006-03-01 | Medical House The Plc | Injection device |
| GB0625169D0 (en) | 2006-12-18 | 2007-01-24 | Medical House Plc The | Improved autoinjector |
| US20080183133A1 (en) | 2007-01-30 | 2008-07-31 | Animas Corporation | Infusion pump keypad assembly and method for making the same |
| US20080249927A1 (en) | 2007-04-06 | 2008-10-09 | Rethorn Michael L | Remittance recipient/sender name on sender/recipient monthly statement |
| US8043075B2 (en) | 2007-06-19 | 2011-10-25 | Smiths Medical Asd, Inc. | Progressive cavity propagation pump |
| EP2080532B1 (de) * | 2008-01-17 | 2010-12-01 | Peter Loos und Arnold Neuhold Gewerbliche Schutzrechte GbR | Kartusche für ein Autoinjektor und System bestehend aus einer solchen Kartusche und einem Autoinjektor |
| US20090209883A1 (en) | 2008-01-17 | 2009-08-20 | Michael Higgins | Tissue penetrating apparatus |
| MX2010012691A (es) * | 2008-05-20 | 2011-03-30 | Avant Medical Corp Star | Sistema auto-inyector. |
| US8048029B2 (en) * | 2008-06-20 | 2011-11-01 | West Pharmaceutical Services, Inc. | Injector apparatus |
| LT2326371T (lt) | 2008-07-18 | 2019-12-10 | Ucb Biopharma Sprl | Sistemos, skirtos įvedimui vaisto, skirto pacientams sergantiems reumatoidiniu artritu |
| GB2463034B (en) * | 2008-08-28 | 2012-11-07 | Owen Mumford Ltd | Autoinjection devices |
| GB2463071A (en) * | 2008-09-02 | 2010-03-03 | Owen Mumford Ltd | Auto-injector syringe with safety shield |
| GB0823066D0 (en) * | 2008-12-18 | 2009-01-28 | Medical House Plc The | Safety syringe for autoinjector |
| GB0900930D0 (en) * | 2009-01-20 | 2009-03-04 | Future Injection Technologies Ltd | Injection device |
| USD660958S1 (en) | 2009-07-20 | 2012-05-29 | Ucb Pharma, S.A. | Device for administering medication |
| CN102470217B (zh) * | 2009-07-31 | 2014-09-17 | Shl集团有限责任公司 | 药物容器保持器装置 |
| JP5856966B2 (ja) * | 2009-10-30 | 2016-02-10 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 薬物送達デバイス |
| GB2475917B (en) | 2009-12-07 | 2015-12-16 | Medical House Ltd | Syringe flange protector |
| WO2011101376A1 (en) | 2010-02-18 | 2011-08-25 | Sanofi-Aventis Deutschland Gmbh | Clutch mechanism |
| EP2536451B1 (en) | 2010-02-18 | 2018-03-28 | Sanofi-Aventis Deutschland GmbH | Auto-injector with a torsion spring |
| DK2536452T3 (da) | 2010-02-18 | 2019-01-02 | Sanofi Aventis Deutschland | Autoinjektor |
| EP2364740A1 (en) | 2010-03-09 | 2011-09-14 | Sanofi-Aventis Deutschland GmbH | Arrangement for transferring a translation of a drive means to a plunger |
| EP2364739A1 (en) | 2010-03-09 | 2011-09-14 | Sanofi-Aventis Deutschland GmbH | Re-usable autoinjector |
| CN102791917B (zh) | 2010-03-12 | 2014-11-05 | 埃克森美孚化学专利公司 | 制备耐热无纺织物的方法 |
| CN103153367A (zh) * | 2010-08-13 | 2013-06-12 | 赛诺菲-安万特德国有限公司 | 用于药物输送装置贮液器的连接器 |
| JP5620777B2 (ja) | 2010-10-07 | 2014-11-05 | 株式会社カネカ | 熱可塑性樹脂組成物および成形体 |
| EP2438939A1 (en) | 2010-10-08 | 2012-04-11 | Sanofi-Aventis Deutschland GmbH | Arrangement for coupling a plunger to either a syringe or a stopper |
| TWI459986B (zh) * | 2010-11-08 | 2014-11-11 | Shl Group Ab | 容器支撐總成 |
| GB201021777D0 (en) | 2010-12-22 | 2011-02-02 | Owen Mumford Ltd | Autoinjectors |
| EP2474332A1 (en) * | 2011-01-07 | 2012-07-11 | Sanofi-Aventis Deutschland GmbH | Cartridge holder for an injection device |
| MY166835A (en) | 2011-01-24 | 2018-07-23 | Abbvie Biotechnology Ltd | Automatic injection devices having overmolded gripping surfaces |
| CA2833748C (en) | 2011-04-20 | 2019-07-16 | Amgen Inc. | Autoinjector apparatus |
| CA2832729A1 (en) | 2011-04-21 | 2012-10-26 | Abbvie Inc. | Wearable automatic injection device for controlled administration of therapeutic agents |
| AU2012269770B2 (en) | 2011-06-17 | 2015-04-16 | Shl Medical Ag | Injection device |
| KR101664632B1 (ko) | 2011-09-27 | 2016-10-24 | 에스에이치엘 그룹 에이비 | 최초 로크된 상태, 중간 프라이밍 상태, 및 약물 주입 상태를 갖는 약물 주입 장치 |
| BR112014012611A8 (pt) * | 2011-11-25 | 2017-06-20 | Shl Group Ab | dispositivo de administração de medicamento |
| EP2789357B1 (en) | 2011-12-09 | 2017-04-26 | Panasonic Healthcare Holdings Co., Ltd. | Pharmaceutical syringe unit and pharmaceutical injection device |
| KR101924310B1 (ko) | 2011-12-15 | 2018-11-30 | 에스에이치엘 그룹 에이비 | 자동 주입 장치 |
| US10973981B2 (en) | 2012-08-31 | 2021-04-13 | Sanofi-Aventis Deutschland Gmbh | Medical device with impact resistant housing |
| US8591463B1 (en) | 2013-03-08 | 2013-11-26 | Teva Pharmaceutical Industries Ltd. | Re-useable injector device for syringe |
| US10898646B2 (en) | 2016-04-29 | 2021-01-26 | Shl Medical Ag | Container holder assembly |
-
2013
- 2013-08-02 GB GBGB1313888.8A patent/GB201313888D0/en not_active Ceased
-
2014
- 2014-08-04 GB GB1413766.5A patent/GB2519196B/en active Active
- 2014-08-04 CA CA2919195A patent/CA2919195C/en active Active
- 2014-08-04 WO PCT/GB2014/052387 patent/WO2015015230A2/en not_active Ceased
- 2014-08-04 AU AU2014298151A patent/AU2014298151B2/en active Active
- 2014-08-04 JP JP2016530615A patent/JP6667165B2/ja active Active
- 2014-08-04 BR BR112016002188-6A patent/BR112016002188B1/pt active IP Right Grant
- 2014-08-04 US US14/909,689 patent/US10500341B2/en active Active
- 2014-08-04 CN CN201480043365.0A patent/CN105555337B/zh active Active
- 2014-08-04 ES ES14749996T patent/ES2861348T3/es active Active
- 2014-08-04 EP EP14749996.6A patent/EP3027248B1/en active Active
-
2019
- 2019-11-11 US US16/679,661 patent/US11517676B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB201313888D0 (en) | 2013-09-18 |
| WO2015015230A2 (en) | 2015-02-05 |
| JP6667165B2 (ja) | 2020-03-18 |
| CN105555337B (zh) | 2020-08-21 |
| AU2014298151A1 (en) | 2016-02-11 |
| EP3027248B1 (en) | 2021-03-17 |
| US11517676B2 (en) | 2022-12-06 |
| EP3027248A2 (en) | 2016-06-08 |
| CN105555337A (zh) | 2016-05-04 |
| GB2519196A (en) | 2015-04-15 |
| GB2519196B (en) | 2020-05-13 |
| US20160175531A1 (en) | 2016-06-23 |
| ES2861348T3 (es) | 2021-10-06 |
| US20200069878A1 (en) | 2020-03-05 |
| AU2014298151B2 (en) | 2019-07-25 |
| US10500341B2 (en) | 2019-12-10 |
| WO2015015230A3 (en) | 2015-06-11 |
| CA2919195A1 (en) | 2015-02-05 |
| BR112016002188A2 (pt) | 2017-08-01 |
| BR112016002188B1 (pt) | 2021-12-14 |
| GB201413766D0 (en) | 2014-09-17 |
| JP2016525425A (ja) | 2016-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11517676B2 (en) | Assembly for an autoinjector device | |
| EP3380140B1 (en) | Auto-injector | |
| US20250242114A1 (en) | Cap | |
| CN104470560B (zh) | 用于药剂输送装置的制动机构 | |
| US10272234B2 (en) | Devices for targeted delivery of therapeutic implants | |
| CN105579083A (zh) | 自动注射器 | |
| US10874800B2 (en) | Medicament injection device | |
| US12485231B2 (en) | Cap | |
| US12420017B1 (en) | Damping device for a medicament delivery device | |
| HK40059450B (en) | A cap | |
| HK40059450A (en) | A cap | |
| HK1188161A1 (en) | Auto-injector |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190802 |